We are developing nucleic acid preparation, MDx and CDx technology targeting various infectious diseases and genetic disorders including COVID-19, mycobacterium tuberculosis, fungal diseases, rickettsial diseases and liquid biopsy from cancers.
Our development goal is 1) to realize prompt and accurate MDx even when there are low quantity of pathogens by using larger quantities of samples than conventional methods, 2) release innovative products that can overcome current diagnostic limitations.
Additional Info
We will be displaying a new product or promoting a new indication/enhanced feature for an existing product in our booth!
YesIncluded in the Export Interest Directory?
NoProducts to be exported:
1) Nucleic extraction kits from various specimens and disease pathogens, 2) qRT-PCR kits targeting various infectious diseases and genetic disordersBusiness Needs:
Direct Sales, Distributor/Agent/Representative, Investor, Joint Ventures, Licensing Agreements, Other, Service (Maintenance, Training, Logistics, etc.)